Therapy News and Research

RSS

Isolating Single T-cells of Interest using an Optofluidic Platform

Researchers are in desperate need of single-cell analysis techniques and those that allow the isolation of high-value T-cells for research and development.

From Bruker Cellular Analysis 21 Feb 2020

Administering immunotherapy alongside chemoradiation for advanced NSCLC appears to be safe and tolerable

Research from Rutgers Cancer Institute of New Jersey shows administering the immunotherapy drug pembrolizumab together with chemotherapy given at the same time as radiation treatment (chemoradiation) is safe and tolerable as a first-line therapy for patients with stage 3 non-small cell lung cancer.

21 Feb 2020

HCI at University of Utah to host 7th annual Metastatic Breast Cancer Research Conference

The 7th annual Metastatic Breast Cancer Research Conference will be hosted by Huntsman Cancer Institute at the University of Utah in partnership with Baylor College of Medicine and Theresa's Research Foundation on September 10 and 11, 2020.

21 Feb 2020

Researchers develop novel therapy to combat antibiotic-resistant superbug infections

There may be a solution on the horizon to combating superbug infections resistant to antibiotics. The tenacious bacteria and fungi sicken more than 2.8 million people and lead to more than 35,000 deaths in the United States each year.

20 Feb 2020

Scientists make important discovery with implications for people living with AMD

Scientists from Trinity College Dublin have made an important discovery with implications for those living with a common, debilitating eye disease (age-related macular degeneration, AMD) that can cause blindness.

20 Feb 2020

Researchers reveal new vulnerability in MYC-driven lymphomas

Walter and Eliza Hall Institute researchers have revealed a new vulnerability in lymphomas that are driven by one of the most common cancer-causing changes in cells.

20 Feb 2020

Global study shows long-term survival benefit for a subset of patients with advanced lung cancer

According to the results of a large, global study led by Yale Cancer Center researchers, even a tiny amount of a biomarker known as PD-L1 (programmed death-ligand1) can predict a long-term survival benefit from using pembrolizumab (Keytruda).

20 Feb 2020

'Stranger Things' increased public awareness of cleidocranial dysplasia

A new study published in February 2020 in the journal JAMA Otolaryngology-Head and Neck Surgery shows that using mainstream media to depict rare diseases in a realistic manner can prompt greater public awareness and support for such conditions.

20 Feb 2020

New study uncovers human genes controlling HIV infection

Viruses are parasites. The only way they can grow is by hijacking their hosts. When they infect a human host, viruses use human proteins to multiply and modify the human cells to sustain the infection. At the same time, the human host activates defense mechanisms to fight the infection.

20 Feb 2020

Study: About 8% of West Virginia newborns are exposed to alcohol few weeks before birth

About 8 percent of West Virginia newborns are exposed to alcohol two to four weeks before birth, according to a new study.

20 Feb 2020

Therapeutic hypothermia effectively targets brain injury sites

When a newborn suffers lack of oxygen before or during birth, doctors have very little time to save precious brain tissue.

20 Feb 2020

Targeted combinatorial drug treatment restores beta cell function in mice

The loss of the identity of insulin-secreting beta cells in the islet of Langerhans, a process also called beta cell dedifferentiation, has been proposed to be a main reason for the development of diabetes.

20 Feb 2020

KHN’s ‘What the Health?’: The labor pains of ‘Medicare for All’

Labor unions are divided over whether to endorse a Democratic candidate for president in 2020 — and, if so, whom to choose.

20 Feb 2020

Intracranial stent appears to be safe and effective for reducing recurrent stroke risk

A brain stent appears safe and effective for reducing the risk of recurrent stroke in patients with cholesterol-clogged brain arteries, according to late breaking science presented today at the American Stroke Association's International Stroke Conference 2020.

20 Feb 2020

Therapy News and Research

Isolating Single T-cells of Interest using an Optofluidic Platform

Administering immunotherapy alongside chemoradiation for advanced NSCLC appears to be safe and tolerable

HCI at University of Utah to host 7th annual Metastatic Breast Cancer Research Conference

Researchers develop novel therapy to combat antibiotic-resistant superbug infections

Scientists make important discovery with implications for people living with AMD

Researchers reveal new vulnerability in MYC-driven lymphomas

Global study shows long-term survival benefit for a subset of patients with advanced lung cancer

'Stranger Things' increased public awareness of cleidocranial dysplasia

New study uncovers human genes controlling HIV infection

Study: About 8% of West Virginia newborns are exposed to alcohol few weeks before birth

Therapeutic hypothermia effectively targets brain injury sites

Targeted combinatorial drug treatment restores beta cell function in mice

KHN’s ‘What the Health?’: The labor pains of ‘Medicare for All’

Intracranial stent appears to be safe and effective for reducing recurrent stroke risk

New breakthrough offers hope for potential treatment of rare childhood epilepsy

Purdue scientists receive $3.2 million NIH grant to target antimicrobial resistance

Researchers identify a protein that aids in colorectal cancer metastasis

Researchers design new drug cocktail to kill brain and soft tissue cancers

Plant-based relatives of cholesterol could boost gene-infused nanoparticle delivery

Patients with type 2 diabetes who decline insulin therapy had worse blood sugar control

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News